| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/10/1999 | WO1999020756A3 Human toll homologues |
| 09/10/1999 | CA2322505A1 Production of mycobacterial polypeptides by lactic acid bacteria |
| 09/10/1999 | CA2249041A1 Novel compounds |
| 09/08/1999 | EP0940468A1 Humanized antibody variable domain |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939818A1 Recombinant toxin fragments |
| 09/08/1999 | EP0939769A1 Vertebrate smoothened proteins |
| 09/08/1999 | EP0939767A1 Modified factor viii |
| 09/08/1999 | CN1227846A Process for producing hydrophobic polypeptides, proteins or peptides |
| 09/07/1999 | US5948889 Purified bacterial cell division protein for screening libraries of compounds |
| 09/07/1999 | CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same |
| 09/07/1999 | CA2125486C Platelet gpiiia p1 a1 and p1 a2 epitopes, their preparation and use |
| 09/07/1999 | CA2072982C Hepatitis a vaccines |
| 09/07/1999 | CA1340729C Ryegrass pollen allergen |
| 09/02/1999 | WO1999043828A1 Human homolog of the drosophila protein 'fused' |
| 09/02/1999 | WO1999043808A1 Human c-maf compositions and methods of use thereof |
| 09/02/1999 | WO1999043713A1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/02/1999 | WO1999043703A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 09/02/1999 | WO1999033488A3 Adjuvanted vaccine formulation |
| 09/02/1999 | WO1999023116A9 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 09/02/1999 | WO1999002711A3 Fusion proteins with an immunoglobulin hinge region linker |
| 09/02/1999 | CA2320403A1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 09/02/1999 | CA2287226A1 Human c-maf compositions and methods of use thereof |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0938679A2 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay |
| 09/01/1999 | EP0938571A1 Method for the oligomerisation of peptides |
| 09/01/1999 | EP0938556A1 Gamma-heregulin |
| 09/01/1999 | CN1227604A Multivarient IL-3 hematopoiesis fusion protein |
| 08/31/1999 | US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents |
| 08/31/1999 | US5945512 An antibody against amino-terminated peptide for the detection of diabetic vascular disorders |
| 08/31/1999 | US5945274 Quantitative analysis of free lysylpyridinoline in a urine sample and correlating it to bone resorption in vivo wherein urine sample is hydrolyzed |
| 08/26/1999 | WO1999042597A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor |
| 08/26/1999 | WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF |
| 08/26/1999 | WO1999042121A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | WO1999042118A2 Compounds and methods for diagnosis of tuberculosis |
| 08/26/1999 | WO1999042077A2 Compositions and methods for regulating lymphocyte activation |
| 08/26/1999 | WO1999029732A3 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 08/26/1999 | WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/26/1999 | DE19909251A1 Agents for treating human diseases, particularly cancer, modulate interaction of beta-catenin with transcription factors or tumor suppressor gene products |
| 08/26/1999 | CA2357015A1 Agents for treating human illnesses based on .beta.-catenin, and the production and use thereof |
| 08/26/1999 | CA2322617A1 Compounds and methods for diagnosis of tuberculosis |
| 08/26/1999 | CA2321262A1 Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor |
| 08/26/1999 | CA2321199A1 Compositions and methods for regulating lymphocyte activation |
| 08/26/1999 | CA2321101A1 Modified heat shock protein-antigenic peptide complex |
| 08/25/1999 | EP0937098A1 Recombinational cloning using engineered recombination sites |
| 08/25/1999 | EP0937095A1 Targeted cytolysis of cancer cells |
| 08/24/1999 | US5942400 Assays for detecting β-secretase |
| 08/24/1999 | US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form |
| 08/24/1999 | US5942229 Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent |
| 08/24/1999 | CA2248972A1 Novel compounds |
| 08/19/1999 | WO1999041383A1 Antigen library immunization |
| 08/19/1999 | WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | WO1999041258A1 Novel dimerizing agents, their production and use |
| 08/19/1999 | WO1999023236A9 Method of dna shuffling |
| 08/19/1999 | CA2320958A1 Antigen library immunization |
| 08/19/1999 | CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | CA2319492A1 Novel dimerizing agents, their production and use |
| 08/18/1999 | EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY |
| 08/18/1999 | EP0935612A1 Precursors of catalytic antibodies |
| 08/18/1999 | EP0935609A1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
| 08/18/1999 | EP0935607A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/18/1999 | CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium |
| 08/18/1999 | CN1226172A Method and compositions useful for inhibiting angiogenesis |
| 08/17/1999 | US5939598 Method of making transgenic mice lacking endogenous heavy chains |
| 08/17/1999 | US5939524 Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use |
| 08/17/1999 | US5939386 Growth hormone (gh) or somatotropin, secreted by the pituitary gland constitute a family of hormones |
| 08/17/1999 | US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them |
| 08/17/1999 | US5939274 Immunological binding antibodies or fragments capable of specifically binding to peptide fragment derived from bone collagen |
| 08/17/1999 | US5939073 Fish pancreatic disease virus |
| 08/12/1999 | WO1999040196A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 08/12/1999 | WO1999040188A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations |
| 08/12/1999 | WO1999022761A9 Conjugate heat shock protein-binding peptides |
| 08/12/1999 | WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 08/12/1999 | CA2319236A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 08/11/1999 | EP0934425A1 Renilla luciferase and green fluorescent protein fusion genes |
| 08/11/1999 | EP0934333A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 08/11/1999 | EP0835323A4 Modified proteins and methods of their production |
| 08/11/1999 | EP0701572B1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv |
| 08/11/1999 | CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity |
| 08/11/1999 | CN1225368A Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein |
| 08/10/1999 | US5935823 Inserting randomly synthesized fusion nucleotide sequences into vectors producing library transforming cells, screening expressed fusion proteins for sensitivity to ligands; efficient, simple and reproducible |
| 08/10/1999 | US5935821 Nucleotide sequence that codes polypeptide anti-idiotype immunoglobulin a ganglioside useful in the suppression of cancer and reduction of recurrence; anticarcinogenic agents |
| 08/10/1999 | US5935819 Process for producing a pharmaceutical preparation of PDGF-AB |
| 08/10/1999 | US5935792 KUZ, a novel family of metalloproteases |
| 08/10/1999 | US5935579 A peptide will stimulate proliferation of a t-cell clone in a t-cell proliferation assay and produce an alloepitopic effect, peptide when administered in a tolerizing amount will suppress proliferation of t-cell clone in second assay |
| 08/10/1999 | US5935574 Saccharomyces-specific antigens and their use |
| 08/10/1999 | US5935565 Method for increasing the level of stem cells in peripheral blood |
| 08/10/1999 | CA2136208C Improved methods for the preparation of endotoxin-binding proteins |
| 08/10/1999 | CA2126863C Chimeric immunogens |
| 08/05/1999 | WO1999038973A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 08/05/1999 | WO1999038967A2 Recombinant proteins derived from hgf and msp |
| 08/05/1999 | WO1999023116B1 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 08/05/1999 | WO1999021999A3 Wnt-1 inducible genes |
| 08/05/1999 | WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 08/05/1999 | WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 08/05/1999 | CA2319117A1 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 08/04/1999 | EP0933082A1 Methods of manipulation of cell differentiation |